查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018581

CBD寵物市場：2026-2032年全球市場預測（按形態、目標動物、通路和應用分類）

CBD Pet Market by Form, Animal Type, Distribution Channel, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年 CBD 寵物市場價值 3.7024 億美元，預計到 2026 年將成長至 4.1834 億美元，複合年成長率為 15.51%，到 2032 年將達到 10.1609 億美元。

主要市場統計數據
基準年 2025 3.7024億美元
預計年份：2026年 4.1834億美元
預測年份 2032 1,016,090,000 美元
複合年成長率 (%) 15.51%

這篇以證據為基礎的介紹概述了 CBD 寵物市場的演變以及影響產品安全性、可靠性和商業化的匯聚因素。

大麻二酚 (CBD) 在伴侶動物中的應用正迅速從實驗性的小眾配方發展成為一個更加規範的產品類型，其中獸醫學、寵物護理和受監管的健康益處聲明相互交織。寵物飼主越來越將他們的犬貓視為家庭成員，並要求治療產品具備與人類產品相同的安全性和透明度。這些不斷成長的期望迫使製造商和零售商採取更嚴格的成分揭露、第三方檢測和科學傳播措施，產品宣傳也從單純的軼事轉向基於證據的定位。同時，監管機構和獸醫協會日益嚴格的審查也迫使行業相關人員在產品創新、合規性和負責任的行銷之間取得平衡。

消費者期望的改變、專家的認可和監管的明確化如何將 CBD 寵物產品類別轉變為具有標準化安全性和治療可信度的類別。

過去幾年，CBD寵物產品類型已從分散的手工生產模式轉變為以集中創新、專業化生產和數據驅動行銷為特徵的模式。消費者現在要求產品劑量穩定、純度經實驗室檢驗且使用方法清晰，這迫使品牌投資於標準化配方和生產控制。同時，獸醫專業人士的態度也從懷疑轉變為有條件接受，尤其是在有嚴格的安全數據和透明的採購流程的情況下。這種轉變提高了市場進入門檻，並凸顯了可靠的臨床證據對於支持有關焦慮管理、運動功能支持、疼痛緩解和皮膚健康等方面的功效聲明的重要性。

該評估旨在評估美國近期關稅調整如何重塑 CBD 寵物產品供應鏈，並促進向韌性、可追溯性和國內採購的策略轉變。

美國關稅政策近期的變化為依賴跨境供應鏈獲取植物來源原料、成品或製造服務的企業帶來了新的挑戰。傳統上從國際供應商採購大麻萃取物、載體油或包裝材料的企業正面臨採購成本上升的困境，需要重新評估其供應商多元化策略，以維持利潤率和產品品質的穩定性。這種影響不僅限於直接的成本壓力，還包括更長的前置作業時間、更高的庫存持有成本，以及為了降低地緣政治風險而更加重視近岸外包和國內夥伴關係。

細分市場的具體影響因產品形式、動物種類、分銷管道和治療應用而異，指南有針對性的產品開發、定位和商業化策略。

細分市場分析揭示了不同劑型、動物種類、分銷管道和使用場景的擴散模式和戰略挑戰。就產品劑型而言，油劑因其易於給藥和用途廣泛而仍佔據主導地位，但對高、中、低濃度油劑的需求細分，為構建分層產品系列創造了機會，以滿足不同飼主的知識水平和獸醫的指導需求。膠囊劑型更受老年寵物青睞，因為精準的給藥計畫和便捷的給藥方式至關重要。另一方面，外用製劑滿足局部護膚需求，並在獸醫診所和專科機構中發揮重要的溝通橋樑作用。零食是一種偏好極佳的給藥方式，鼓勵寵物嘗試使用，而培根、雞肉和花生醬等口味變化是影響犬類（在某些情況下也包括貓類）重複購買的關鍵因素。

主要地區監管立場、消費者知識水準和分銷管道結構方面的差異，使得市場准入、合規和夥伴關係策略必須個性化。

區域趨勢顯示，監管環境、消費者行為和流通結構存在顯著差異，因此需要製定個人化的市場進入和業務拓展策略。在美洲，消費者對CBD的熟悉程度以及成熟的電子商務環境促使他們快速試用，但監管政策的差異以及各州之間的差異要求企業製定周密的法律和合規計劃，以避免虛假宣傳和未經授權的功效聲明。在該地區運營的品牌發現，投資第三方檢測、打造清晰的產品故事以及與獸醫診所建立合作關係，能夠提升品牌信譽，並透過專業零售商和獸醫管道促進產品推廣。

以品質主導差異化、策略製造夥伴關係和通路創新為特徵的競爭格局正在決定永續的競爭優勢。

競爭動態由眾多參與者共同塑造，從探索天然輔助療法的成熟動物用藥品公司到專注於大麻素寵物護理的專業Start-Ups，不一而足。主要企業透過投資生產品質、臨床檢驗和透明的供應鏈實踐來脫穎而出，從而建立值得信賴的產品故事。擁有符合GMP標準的生產設施和檢驗的分析能力的契約製造製造商和聯合包裝合作夥伴，實際上已成為戰略合作夥伴，幫助品牌在保持合規性和一致性的同時拓展業務。

整合品質保證、臨床檢驗、供應鏈彈性和全通路部署的實用建議，以加速可靠成長。

產業領導企業應優先考慮採取協調一致的方法，平衡監管合規、臨床檢驗和跨通路商業化。首先，企業需要投資嚴格的品質保證系統和透明的第三方檢測，建立從原料到成品的可追溯性，從而在確保安全性的同時滿足監管應對力。同時，針對焦慮管理、運動功能支持、疼痛緩解以及皮膚發炎和搔癢等問題開展有針對性的臨床試驗和真實世界數據（REW）項目，將顯著提升產品功效聲明的可信度，並加強與獸醫專業人士的聯繫。

採用綜合混合方法的研究途徑，結合專家訪談、產品審核以及監管和臨床文獻審查，確保研究結果的可靠性和可重複性。

本調查方法結合了定性訪談、結構化專家諮詢、產品配方審核以及對監管文件和臨床文獻的系統性二次檢驗，以三角驗證研究結果。主要研究包括對獸醫、產品開發人員、採購經理和零售品類經理進行結構化訪談，以確定實際限制因素和推廣促進因素。產品審核則審查了標籤、檢測結果揭露、劑量指導和包裝內容，以評估市場層級的合規性和消費者透明度。

結論強調了證據、透明度和供應鏈韌性對於可擴展和負責任的成長的重要性。

CBD寵物產品市場正處於轉折點，嚴格的品管、以臨床為導向的產品研發以及完善的銷售管道，能夠將早期用戶的興趣轉化為持續的治療地位。成功的關鍵在於企業能否在複雜的法規環境和供應鏈壓力下，透過可靠的測試和有針對性的證據產生來證明產品的安全性和有效性。那些重視透明度、投資專家夥伴關係並採用穩健採購模式的企業，將更有利於贏得獸醫的支持和消費者的信任，從而在這個日趨成熟的市場中脫穎而出。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：CBD寵物市場：依形式分類

  • 膠囊
  • 油
    • 高濃度
    • 低濃度
    • 中等濃度
  • 外用製劑
  • 小吃
    • 培根口味
    • 雞肉口味
    • 花生醬口味

第9章：CBD寵物市場：依動物類型分類

  • 貓
  • 狗

第10章：CBD寵物市場：依通路分類

  • 線上
    • 品牌官方網站
    • 電子商務平台
    • 市場
  • 寵物專賣店
  • 藥局
  • 動物醫院

第11章：CBD寵物市場：依應用領域分類

  • 焦慮管理
  • 運動功能支持
  • 緩解疼痛
  • 護膚
    • 發炎
    • 癢

第12章：CBD寵物市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：CBD寵物市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：CBD寵物市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國CBD寵物市場

第16章：中國CBD寵物市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abacus Health Products
  • Austin and Kat
  • BATCH CBD
  • Bluebird Botanicals
  • Canna-Pet
  • CBDistillery
  • cbdMD, Inc.
  • Charlotte's Web Holdings, Inc.
  • CV Sciences, Inc.
  • FOCL
  • Green Roads
  • HempMeds
  • HolistaPet
  • Joy Organics
  • Kazmira LLC
  • King Kanine
  • Lazarus Naturals
  • Medterra CBD
  • Penelope's Bloom
  • Pet Releaf
  • PureKana
  • VetCS
  • Wesley Edens
Product Code: MRR-B9334AD6C1DD

The CBD Pet Market was valued at USD 370.24 million in 2025 and is projected to grow to USD 418.34 million in 2026, with a CAGR of 15.51%, reaching USD 1,016.09 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 370.24 million
Estimated Year [2026] USD 418.34 million
Forecast Year [2032] USD 1,016.09 million
CAGR (%) 15.51%

An evidence-oriented introduction that frames the evolving CBD pet landscape and the converging forces shaping product safety, trust, and commercialization

The landscape for cannabidiol (CBD) applications in companion animals has evolved rapidly from experimental niche formulations to a more structured product category that intersects veterinary medicine, consumer pet care, and regulated health claims. Pet owners increasingly treat their animals as family members and demand therapeutic products that mirror human-grade safety and transparency. This growing expectation has compelled manufacturers and retailers to adopt more rigorous ingredient disclosure, third-party testing, and scientific communication, shifting product narratives away from anecdote and toward evidence-informed positioning. Concurrently, regulators and veterinary associations have elevated scrutiny, prompting industry participants to reconcile product innovation with compliance and responsible marketing.

This introduction frames the subsequent analysis by clarifying the principal drivers of category maturation: consumer sophistication, distribution channel sophistication, formulation diversification, and regulatory oversight. It highlights how these drivers interact, creating both opportunities and constraints for companies that aim to scale. The section also sets the analytical tone for the report by emphasizing a balanced view that recognizes legitimate therapeutic promise while insisting on robust safety and efficacy validation. Readers should expect an evidence-oriented approach that prioritizes practical guidance for product development, channel strategies, and stakeholder engagement across the pet care ecosystem.

How evolving consumer expectations, professional acceptance, and regulatory clarity are collectively transforming the CBD pet category toward standardized safety and therapeutic credibility

Over the past several years the CBD pet category has shifted from a fragmented assortment of artisanal products toward a market characterized by concentrated innovation, professionalized manufacturing, and data-driven marketing. Consumers now seek products that demonstrate consistent dosing, lab-verified purity, and clear application profiles, which has pushed brands to invest in standardized formulations and manufacturing controls. At the same time, veterinary professionals have moved from skepticism toward conditional acceptance, especially when products are accompanied by rigorous safety data and transparent sourcing. This shift has generated a higher bar for entry and elevated the importance of credible clinical evidence to support claims about anxiety management, mobility support, pain relief, and skin health.

Distribution has transformed in parallel. E-commerce channels have matured to support repeat purchase behavior through subscription options and tailored education, while brick-and-mortar pet specialty retailers and veterinary clinics emphasize curated assortments that align with professional recommendations. The regulatory environment has added another layer of transformation: clearer enforcement priorities and evolving frameworks for permissible claims have forced companies to refine labeling, invest in compliance, and engage proactively with advisors and policymakers. Collectively, these changes are enabling a transition from experimental consumer trial to sustained therapeutic positioning for products that can demonstrably meet pet health needs.

Assessing how recent United States tariff adjustments are reshaping CBD pet supply chains and driving strategic shifts toward resilience, traceability, and domestic sourcing

Recent tariff policy shifts in the United States have introduced new layers of complexity for firms that rely on cross-border supply chains for botanical inputs, finished products, or manufacturing services. Companies that historically sourced raw hemp extracts, carrier oils, or packaging components from international suppliers face elevated procurement costs and must re-evaluate supplier diversification strategies to maintain margin and product consistency. The cumulative impact extends beyond direct cost pressures to include prolonged lead times, increased inventory carrying considerations, and a renewed emphasis on nearshoring or domestic partnerships to mitigate geopolitical exposure.

As a practical consequence, product roadmaps and launch timelines are under greater scrutiny. Procurement teams are increasingly tasked with dual objectives: secure raw material quality while reducing logistical vulnerability. This dynamic incentivizes vertical integration for some manufacturers and strategic contracting for others, such as long-term supply agreements with certified domestic processors or shared-risk co-manufacturing arrangements. In addition, the tariff-driven reconfiguration of supply chains is accelerating investments in quality assurance infrastructure and traceability systems, which in turn enhance product safety narratives and can serve as competitive differentiators in channels that demand proven provenance and compliance.

Segment-specific implications across form, animal type, channel, and therapeutic application that inform targeted product development, positioning, and commercialization strategies

Segmentation analysis reveals differentiated adoption patterns and tactical imperatives across form factors, animal types, distribution channels, and application use-cases. In terms of product form, oils remain central due to ease of dosing and perceived versatility, but demand segmentation between high concentration, medium concentration, and low concentration oils creates opportunities for tiered portfolios that match owner sophistication and veterinary guidance. Capsules appeal to precision dosing regimens and older pet populations where ease of administration is critical, whereas topicals meet localized skin care needs and create strong point-of-sale conversation starters in clinic and specialty settings. Treats provide a palatable delivery vehicle that can accelerate trial, with flavor variants such as bacon, chicken, and peanut butter proving to be important determinants of repeat purchase among dogs and in some cases cats.

Animal type segmentation between cats and dogs shapes formulation, palatability research, and dosage communication, as feline and canine physiology and behavior influence both efficacy patterns and product acceptance. Distribution channel differentiation underscores the necessity of omnichannel strategies: online platforms, which include brand websites, e-commerce platforms, and marketplaces, enable subscription models, targeted education, and broad reach; pet specialty stores offer curated assortments and staff-mediated recommendations; pharmacies and veterinary clinics provide professional endorsement opportunities and controlled product narratives. Application-focused segmentation-comprising anxiety management, mobility support, pain relief, and skin care with specific attention to inflammation and itching-calls for tailored clinical evidence and targeted messaging that aligns product claims with verifiable outcomes and safety profiles.

How contrasting regulatory attitudes, consumer sophistication, and channel architectures across major regions necessitate tailored market entry, compliance, and partnership strategies

Regional dynamics present distinct regulatory landscapes, consumer behaviors, and channel structures that require bespoke strategies for market entry and scale. In the Americas, consumer familiarity with CBD and a mature e-commerce ecosystem support rapid trial, but regulatory patchworks and state-level variations necessitate careful legal and compliance planning to avoid mislabeling or unauthorized claims. Brands operating in this region find that investments in third-party testing, clear product narratives, and clinic partnerships yield credibility and facilitate placement in both specialty retail and veterinary channels.

In Europe, Middle East & Africa, a more conservative regulatory posture in several jurisdictions coexists with high interest in evidence-backed animal health solutions. Successful approaches in this region prioritize rigorous documentation, collaborations with licensed veterinary professionals, and targeted education for distributors that operate within national regulatory frameworks. Asia-Pacific demonstrates heterogeneous demand driven by rising pet ownership, premiumization trends, and an appetite for trusted imports in some markets. However, companies must navigate diverse import regulations, local manufacturing expectations, and culturally specific preferences for flavors and dosing formats, which underscores the value of strategic local partnerships and adaptive go-to-market models.

Competitive landscape characterized by quality-driven differentiation, strategic manufacturing partnerships, and channel-aligned innovation that determine sustained advantage

Competitive dynamics are shaped by a spectrum of actors ranging from established animal health companies exploring adjunct natural remedies to specialized start-ups focused exclusively on cannabinoid-based pet care. Leading players differentiate through investments in manufacturing quality, clinical validation, and transparent supply chain practices that support credible product narratives. Contract manufacturers and co-packers that demonstrate GMP-aligned facilities and validated analytical capabilities become de facto strategic partners, enabling brands to scale while maintaining compliance and consistency.

Retail and distribution partners exert influence on assortment decisions and educational outreach; veterinary clinics that adopt evidence-aligned products can materially affect adoption through point-of-care recommendations. Emerging innovators are leveraging technology-enabled services such as digital dosing guidance, tele-veterinary support, and subscription fulfillment to enhance adherence and lifetime value. Collectively, these competitive behaviors indicate that sustained advantage will come from integrating product quality, clinical evidence generation, channel-aligned go-to-market models, and customer experience design rather than from single-dimension differentiation.

Actionable recommendations that align quality assurance, clinical validation, supply chain resilience, and omnichannel commercialization to accelerate credible growth

Industry leaders should prioritize a coordinated agenda that balances regulatory compliance, clinical validation, and channel-specific commercialization. First, companies must invest in rigorous quality assurance frameworks and transparent third-party testing, establishing traceability from raw botanical input through finished product to support both safety narratives and regulatory resilience. Concurrently, targeted clinical studies and real-world evidence programs in anxiety management, mobility support, pain relief, and skin-related inflammation and itching will materially enhance the credibility of product claims and strengthen relationships with veterinary professionals.

Operationally, diversify supply chains by developing domestic processing options or long-term partnerships with certified suppliers to reduce exposure to tariff volatility. In channel strategy, adopt an omnichannel approach that leverages brand websites and e-commerce platforms for education and subscription models, while engaging pet specialty retailers and veterinary clinics for endorsement and curated placement. Finally, accelerate consumer education through transparent dosing guides and case studies that respect veterinary oversight, thereby aligning owner expectations with scientific evidence and improving adherence and long-term outcomes.

Comprehensive mixed-methods research approach combining expert interviews, product audits, and regulatory and clinical literature review to ensure robust and reproducible insights

The research methodology combines primary qualitative interviews, structured expert consultations, product formulation audits, and systematic secondary review of regulatory texts and clinical literature to triangulate findings. Primary research included structured interviews with veterinarians, formulators, procurement leaders, and retail category managers to capture real-world operational constraints and adoption drivers. Product audits examined labeling, testing disclosures, dosage guidance, and packaging claims to assess market-level compliance behavior and consumer-facing transparency.

Secondary analysis focused on regulatory guidance documents, peer-reviewed clinical studies, and industry technical standards to validate safety and efficacy narratives. Data triangulation procedures reconciled insights across sources to ensure robustness, and methodological safeguards such as sample stratification by channel and animal type were used to mitigate bias. Throughout the study, emphasis was placed on reproducible processes, transparent inclusion criteria for studies and interviews, and iterative validation with independent subject matter experts to ensure that conclusions are defensible and operationally relevant.

Conclusive synthesis highlighting the imperative for evidence, transparency, and supply chain resilience as decisive factors for scalable, responsible growth

The CBD pet category stands at an inflection point where rigorous quality practices, clinically informed product development, and channel-savvy commercialization can convert early adopter interest into sustained therapeutic positioning. Success will hinge on the ability of companies to demonstrate safety and efficacy through credible testing and targeted evidence generation, while also navigating regulatory complexity and supply chain pressures. Firms that prioritize transparency, invest in professional partnerships, and adopt resilient sourcing models will be better positioned to earn veterinary endorsement and consumer trust, creating defensible differentiation in a maturing market.

Looking ahead, the market will reward those who integrate scientific rigor with customer-centric delivery models and who can translate clinical learnings into accessible, responsibly marketed products. Leaders who move decisively to close evidence gaps, strengthen manufacturing provenance, and tailor distribution approaches by region and channel will capture disproportionate advantage as the category professionalizes. This conclusion underscores a pragmatic path forward: rigorous practices, aligned partnerships, and strategic investments in evidence and supply chain resilience will determine which organizations scale responsibly and effectively.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. CBD Pet Market, by Form

  • 8.1. Capsules
  • 8.2. Oils
    • 8.2.1. High Concentration
    • 8.2.2. Low Concentration
    • 8.2.3. Medium Concentration
  • 8.3. Topicals
  • 8.4. Treats
    • 8.4.1. Bacon Flavor
    • 8.4.2. Chicken Flavor
    • 8.4.3. Peanut Butter Flavor

9. CBD Pet Market, by Animal Type

  • 9.1. Cats
  • 9.2. Dogs

10. CBD Pet Market, by Distribution Channel

  • 10.1. Online
    • 10.1.1. Brand Websites
    • 10.1.2. E-Commerce Platforms
    • 10.1.3. Marketplaces
  • 10.2. Pet Specialty Stores
  • 10.3. Pharmacies
  • 10.4. Veterinary Clinics

11. CBD Pet Market, by Application

  • 11.1. Anxiety Management
  • 11.2. Mobility Support
  • 11.3. Pain Relief
  • 11.4. Skin Care
    • 11.4.1. Inflammation
    • 11.4.2. Itching

12. CBD Pet Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. CBD Pet Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. CBD Pet Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States CBD Pet Market

16. China CBD Pet Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abacus Health Products
  • 17.6. Austin and Kat
  • 17.7. BATCH CBD
  • 17.8. Bluebird Botanicals
  • 17.9. Canna-Pet
  • 17.10. CBDistillery
  • 17.11. cbdMD, Inc.
  • 17.12. Charlotte's Web Holdings, Inc.
  • 17.13. CV Sciences, Inc.
  • 17.14. FOCL
  • 17.15. Green Roads
  • 17.16. HempMeds
  • 17.17. HolistaPet
  • 17.18. Joy Organics
  • 17.19. Kazmira LLC
  • 17.20. King Kanine
  • 17.21. Lazarus Naturals
  • 17.22. Medterra CBD
  • 17.23. Penelope's Bloom
  • 17.24. Pet Releaf
  • 17.25. PureKana
  • 17.26. VetCS
  • 17.27. Wesley Edens

LIST OF FIGURES

  • FIGURE 1. GLOBAL CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CBD PET MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CBD PET MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CBD PET MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CBD PET MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CBD PET MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CBD PET MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CBD PET MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CBD PET MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CBD PET MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CBD PET MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CBD PET MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CBD PET MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CBD PET MARKET SIZE, BY OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CBD PET MARKET SIZE, BY OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CBD PET MARKET SIZE, BY OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CBD PET MARKET SIZE, BY HIGH CONCENTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CBD PET MARKET SIZE, BY HIGH CONCENTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CBD PET MARKET SIZE, BY HIGH CONCENTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CBD PET MARKET SIZE, BY LOW CONCENTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CBD PET MARKET SIZE, BY LOW CONCENTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CBD PET MARKET SIZE, BY LOW CONCENTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CBD PET MARKET SIZE, BY MEDIUM CONCENTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CBD PET MARKET SIZE, BY MEDIUM CONCENTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CBD PET MARKET SIZE, BY MEDIUM CONCENTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CBD PET MARKET SIZE, BY TOPICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CBD PET MARKET SIZE, BY TOPICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CBD PET MARKET SIZE, BY TOPICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CBD PET MARKET SIZE, BY TREATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CBD PET MARKET SIZE, BY TREATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CBD PET MARKET SIZE, BY TREATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CBD PET MARKET SIZE, BY BACON FLAVOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CBD PET MARKET SIZE, BY BACON FLAVOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CBD PET MARKET SIZE, BY BACON FLAVOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CBD PET MARKET SIZE, BY CHICKEN FLAVOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CBD PET MARKET SIZE, BY CHICKEN FLAVOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CBD PET MARKET SIZE, BY CHICKEN FLAVOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CBD PET MARKET SIZE, BY PEANUT BUTTER FLAVOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CBD PET MARKET SIZE, BY PEANUT BUTTER FLAVOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CBD PET MARKET SIZE, BY PEANUT BUTTER FLAVOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CBD PET MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CBD PET MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CBD PET MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CBD PET MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CBD PET MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CBD PET MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CBD PET MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CBD PET MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CBD PET MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CBD PET MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CBD PET MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CBD PET MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CBD PET MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CBD PET MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CBD PET MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CBD PET MARKET SIZE, BY MARKETPLACES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CBD PET MARKET SIZE, BY MARKETPLACES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CBD PET MARKET SIZE, BY MARKETPLACES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CBD PET MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CBD PET MARKET SIZE, BY PET SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CBD PET MARKET SIZE, BY PET SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CBD PET MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CBD PET MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CBD PET MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CBD PET MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CBD PET MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CBD PET MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CBD PET MARKET SIZE, BY ANXIETY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CBD PET MARKET SIZE, BY ANXIETY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CBD PET MARKET SIZE, BY ANXIETY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CBD PET MARKET SIZE, BY MOBILITY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CBD PET MARKET SIZE, BY MOBILITY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CBD PET MARKET SIZE, BY MOBILITY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CBD PET MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CBD PET MARKET SIZE, BY PAIN RELIEF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CBD PET MARKET SIZE, BY PAIN RELIEF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CBD PET MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CBD PET MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CBD PET MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CBD PET MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CBD PET MARKET SIZE, BY INFLAMMATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CBD PET MARKET SIZE, BY INFLAMMATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CBD PET MARKET SIZE, BY ITCHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CBD PET MARKET SIZE, BY ITCHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CBD PET MARKET SIZE, BY ITCHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CBD PET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS CBD PET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL CBD PET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 170. GCC CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 172. GCC CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GCC CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. GCC CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. G7 CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. G7 CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 207. NATO CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. NATO CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 211. NATO CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. NATO CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)